Hardy Alexander 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Hardy Alexander
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-10-31$56.01/sh+300$16,802→ 148,451 total - Tax Payment
Common Stock
2024-11-29$66.03/sh−14,295$943,899→ 134,156 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.